Stock IKM 1NKEMIA IUCT GROUP, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials 1nKemia IUCT Group, S.A.

Equities

IKM

ES0156303002

Pharmaceuticals

Market Closed - BME
Other stock markets
 07:30:11 08/05/2024 pm IST 		5-day change 1st Jan Change
0.31 EUR 0.00% Intraday chart for 1nKemia IUCT Group, S.A. 0.00% 0.00%
30/04 1nKemia IUCT Group, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
2020 Crescent Hill Capital Corporation cancelled the acquisition of unknown stake in 1nKemia IUCT Group, S.A.. CI

Valuation

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Capitalization 1 60.33 61.87 8.659 8.285 8.341 8.341
Enterprise Value (EV) 1 71.81 77.49 26.76 14.88 15.01 14.65
P/E ratio -617 x -85.8 x -0.36 x 2.35 x - -
Yield - - - - - -
Capitalization / Revenue 29.9 x 13.2 x 1.59 x 4.77 x 57.1 x 56.2 x
EV / Revenue 35.6 x 16.5 x 4.9 x 8.57 x 103 x 98.7 x
EV / EBITDA -162 x -94.4 x 9.19 x 24.6 x -55.7 x -82.5 x
EV / FCF -31.4 x -22.7 x 8.94 x 12.2 x -36.1 x -27.4 x
FCF Yield -3.18% -4.4% 11.2% 8.21% -2.77% -3.65%
Price to Book 3.31 x 3.15 x -1.12 x -2.07 x - -
Nbr of stocks (in thousands) 25,562 26,899 26,727 26,727 26,907 26,907
Reference price 2 2.360 2.300 0.3240 0.3100 0.3100 0.3100
Announcement Date 02/05/17 02/05/18 18/10/20 18/10/20 30/04/24 30/04/24
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net sales 1 2.019 4.701 5.461 1.737 0.146 0.1484
EBITDA 1 -0.4422 -0.8205 2.91 0.6052 -0.2696 -0.1775
EBIT 1 -0.6889 -1.117 2.663 0.4823 -0.2835 -0.1834
Operating Margin -34.13% -23.77% 48.77% 27.76% -194.16% -123.58%
Earnings before Tax (EBT) 1 -1.092 -0.976 -15.63 3.431 -2.649 -0.1188
Net income 1 -0.0989 -0.721 -24.32 3.543 -2.649 -0.1134
Net margin -4.9% -15.34% -445.28% 203.94% -1,814.41% -76.42%
EPS 2 -0.003824 -0.0268 -0.9080 0.1317 - -
Free Cash Flow 1 -2.285 -3.407 2.994 1.222 -0.4158 -0.5348
FCF margin -113.17% -72.48% 54.83% 70.37% -284.83% -360.27%
FCF Conversion (EBITDA) - - 102.87% 201.98% - -
FCF Conversion (Net income) - - - 34.51% - -
Dividend per Share - - - - - -
Announcement Date 02/05/17 02/05/18 18/10/20 18/10/20 30/04/24 30/04/24
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net Debt 1 11.5 15.6 18.1 6.6 6.67 6.31
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -25.97 x -19.04 x 6.218 x 10.9 x -24.74 x -35.56 x
Free Cash Flow 1 -2.28 -3.41 2.99 1.22 -0.42 -0.53
ROE (net income / shareholders' equity) -0.56% -3.69% -405% -57.3% 48.5% 1.74%
ROA (Net income/ Total Assets) -1.41% -1.92% 6.16% 3.32% -5.9% -6.34%
Assets 1 7.037 37.51 -394.9 106.8 44.9 1.789
Book Value Per Share 2 0.7100 0.7300 -0.2900 -0.1500 - -
Cash Flow per Share 2 0.0100 0.0100 0.0100 0 - -
Capex 1 0.11 0.6 0.35 0.63 - -
Capex / Sales 5.53% 12.79% 6.42% 36.42% - -
Announcement Date 02/05/17 02/05/18 18/10/20 18/10/20 30/04/24 30/04/24
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Biopharmaceuticals

1st Jan change Capi.
1NKEMIA IUCT GROUP, S.A. Stock 1nKemia IUCT Group, S.A.
0.00% 8.99M
CSL LIMITED Stock CSL Limited
-3.64% 89.33B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+4.08% 41.19B
BIOGEN INC. Stock Biogen Inc.
-15.09% 31.87B
UCB Stock UCB
+53.68% 24.52B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-15.13% 15.68B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-8.63% 12.34B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-40.39% 12.23B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+6.22% 8.83B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-6.08% 8.28B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. IKM Stock
  4. Financials 1nKemia IUCT Group, S.A.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW